With the analysis among 66 patents, we discovered top 32 key players by total patent application. CRISPR Therapeutics AG, Sangamo Therapeutics, Inc., Boehringer Ingelheim International GmbH are dominant in this area. They take 24.24% of the total patent filing.
Massachusetts, United States
Patent: 6
California, United States
Patent: 5
Rheinland-Pfalz, Germany
Patent: 5
Kentucky, United States
Patent: 4
Kentucky, United States
Patent: 3
Beijing Luther Cage Trading Co., Ltd.
Beijing Shi, China
Patent: 3
Basel-Stadt, Switzerland
Patent: 2
New York, United States
Patent: 2
New Jersey, United States
Patent: 2
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
Kentucky, United States
Patent: 4
With the analysis among related 35 patents applied in the last 5 years. We discover 22 most active companies in this area. The fast-growing Regents of the University of California, Academisch Ziekenhuis Maastricht, Korea Research Institute of Bioscience & Biotechnlogy take 40.00% of patent filing during this period.
California, United States
Patent: 7
Kentucky, United States
Patent: 2
Baden-Württemberg, Germany
Patent: 1
With the analysis among related 35 patents in last 5 years, we discover 17 new entrants. Regents of the University of California, Academisch Ziekenhuis Maastricht, Korea Research Institute of Bioscience & Biotechnlogy are the most active new entrants in this area.
California, United States
Patent: 7
Baden-Württemberg, Germany
Patent: 1
Beijing Shi, China
Patent: 1
With the analysis among 53 patents, we discovered top 18 universities and scientific research institutions by total patent application. California Institute of Technology, The Johns Hopkins University, The Johns Hopkins University School of Medicine are dominant in this area. They take 39.62% of the total patent filing.
California, United States
Patent: 9
Tianjin Shi, China
Patent: 2
North Carolina, United States
Patent: 1
Manitoba, Canada
Patent: 1
Zhejiang Sheng, China
Patent: 1
California, United States
Patent: 1